http://www.blueprintmedicines.com
Blueprint Medicines Corporation Company Intro
Protein kinases (enzymes that modify the functions of proteins) are critical to controlling biochemical pathways and are involved in many hallmarks of tumor biology – yet currently approved drugs focus on less than 5% of known kinases.
Industry
Healthcare
Blueprint Medicines Corporation Headquaters
45 Sidney Street
Cambridge,02139
United States
Blueprint Medicines Corporation Share price
22 Apr 2021 01:16 GMT
$94.16
0.35 (0.37 %)
Blueprint Medicines Corporation Market cap
$5.345 B
WMC RANKING
2021
Blueprint Medicines Corporation # 85
BiotechnologyLatest Blueprint Medicines Corporation News
17 Apr 2021
-$1.80 Earnings Per Share Expected for Blueprint Medicines ...
Blueprint Medicines (NASDAQ:BPMC) last released its quarterly earnings results on ... Blueprint Medicines Corporation, a precision therapy company, develops ...
17 Apr 2021
US Fibrodysplasia Ossificans Progressiva Drugs Market 2019 ...
Pfizer Inc, AstraZeneca, Novartis, Regeneron Pharmaceuticals, Inc, and Blueprint Medicines Corporation. US Fibrodysplasia Ossificans Progressiva Drugs ...
17 Apr 2021
-$1.80 Earnings Per Share Expected for Blueprint Medicines ...
Blueprint Medicines (NASDAQ:BPMC) last released its quarterly earnings results on ... Blueprint Medicines Corporation, a precision therapy company, develops ...
WMC Market Score
WMC Market to Revenue Score
Blueprint Medicines Corporation Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Blueprint Medicines Corporation | USD | $66,512 | $427,838 | $-347,694 | $53,660B | 85 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $540,400B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,205,683 | $2,599,993 | $2,711,647 | $569,820B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,069,900 | $2,656,500 | $603,400 | $367,910B | 3 |
| Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $185,950B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Blueprint Medicines Corporation Social Followers vs Top 4 Industry Competitors
Blueprint Medicines Corporation Post vs Top 4 Industry Competitors
Blueprint Medicines Corporation Digital Footprint By Size vs Top 4 Industry Competitors
Blueprint Medicines Corporation Digital Footprint By Change Rate vs Top 4 Industry Competitors
Blueprint Medicines Corporation WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Blueprint Medicines Corporation | 0.72 | 10.92 | 0.32 | 0 | 0 | 0 | 5.62 |
| Regeneron Pharmaceuticals, Inc. | 100 | 23.95 | 7.31 | 0 | 0 | 0 | 15.63 |
| Vertex Pharmaceuticals Incorporated | 67.14 | 35.08 | 2.43 | 0 | 0 | 0 | 18.76 |
| Alexion Pharmaceuticals, Inc. | 65.67 | 100 | 100 | 0 | 0 | 0 | 100 |
| Incyte Corporation | 24.12 | 4.95 | 0.18 | 0 | 0 | 0 | 2.56 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
